Growth

A competitive advantage instills conviction in U.S. chemicals companies

A little-noticed cost benefit could make a big difference for U.S. commodity chemicals firms versus their overseas competitors, says Fidelity's Ashley Fernandes.

  • Low prices for natural gas in the U.S.—a key input in the manufacturing process for many chemicals—is a cost benefit that boosts the potential for faster earnings growth and improved profitability for U.S.-based chemicals manufacturers relative to their competitors abroad, according to Fidelity's Ashley Fernandes.
  • "I believe U.S.-based commodity chemicals companies have several unique advantages," says Fernandes, portfolio manager of Fidelity Advisor® Materials Fund [Fidelity® Select Materials Portfolio]. "First, the stocks' valuations are attractive; in fact, I believe they remain undervalued despite strong appreciation in 2023, given the underlying strength of the businesses and barriers to competitive entry. U.S. companies also have the additional advantage of operating within a relatively strong economy and stable political environment. Most interestingly—to me, however—is that the U.S. chemicals companies enjoy a significant cost advantage, one that I believe is currently underappreciated by investors."
  • The cost factor Fernandes cites is based in the U.S. chemical companies' preferred resource for feedstock—that is, the raw material(s) used in the manufacturing process. Most U.S. chemicals companies employ a process that uses natural gas, whereas European firms generally use an oil-based byproduct in their processes. Natural gas itself is notably less expensive in the U.S. than in Europe, and U.S. natural gas is a lot less expensive than European oil.
  • In managing the fund since 2022, Fernandes follows a contrarian investment approach, focusing on companies with strong fundamentals that have not yet been recognized by the broader market, while also looking for reasonably valued stocks of firms with improving returns on capital and the potential for price-earnings multiple expansion.
  • He underscored that stocks in the materials sector tend to be cyclically driven, meaning that, as a group, they generally have risen when the global economy is growing and have fallen when the outlook is trending down.
  • The sector underperformed the broader market in 2023 as investors waited out the likely end of the U.S. Federal Reserve's aggressive interest-rate-hiking campaign, Fernandes notes. But with rate cuts expected in 2024, the economy could see an uptick in growth this year—to which materials stocks could respond favorably.
  • In 2023, he established a sizable overweight position in commodity chemicals stocks relative to the MSCI U.S. IMI Materials 25/50 Index, the portfolio's sector benchmark.
  • "I knew this was a contrarian position, and I knew the going might be a little rocky at first," says Fernandes. "But looking ahead to the remainder of 2024, what most enthuses me about this positioning is that the stocks are appreciating even though we haven't seen any macroeconomic improvement yet. I believe a cyclical upturn, when it arrives, could take the stocks up even higher.
  • By industry, the commodity chemicals group was a top contributor to the portfolio's performance versus its sector benchmark in 2023. Notable outperformers included Westlake, Cabot and LyondellBasell Industries—all top holdings and sizable overweights in the fund as of February 29.
  • Fernandes concludes, "These U.S.-based commodity chemicals companies began heading in the right direction in the latter part of 2023, and looking ahead, I believe they remain well-positioned for further growth."
  • For specific fund information such as standard performance and holdings, please go to the "Funds Managed" link on this page.
 
 

There was an issue with your input

 
 
 

Please confirm